New Senior Executives appointed at Sanofi
22 July 2011 | By Sanofi
Sanofi is pleased to announce the appointment of Greg Irace, to the newly created role of Senior Vice President, Global Services...
List view / Grid view
22 July 2011 | By Sanofi
Sanofi is pleased to announce the appointment of Greg Irace, to the newly created role of Senior Vice President, Global Services...
22 July 2011 | By Novartis
The Committee for Medicinal Products for Human Use of the EMA adopted a positive opinion for Afinitor® (everolimus) tablets...
22 July 2011 | By Takeda Pharmaceutical Company Limited
The EMA has recommended changes to the label of pioglitazone-containing medicines...
21 July 2011 | By Cephalon, Inc.
The FDA approved the Risk Evaluation and Mitigation Strategy for FENTORA® & ACTIQ®...
21 July 2011 | By GlaxoSmithKline
The EMA's Committee for Medicinal Products for Human Use (CHMP) has recommended an update to the product label, Pandemrix...
21 July 2011 | By Bristol-Myers Squibb
Bristol-Myers Squibb will acquire privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company...
21 July 2011 | By Merck
Merck & Co., Inc., and Simcere announced the signing of a framework agreement to establish a joint venture...
21 July 2011 | By AD Communications Ltd
Brecon Pharmaceuticals, has appointed Charles Evans to the role of operations director...
21 July 2011 | By The Scott Partnership
Novozymes Biopharma, received the 2011 NEP Business Award...
21 July 2011 | By
The Gastrointestinal Drugs Advisory Committee (GIDAC) of the U.S. FDA recommended the approval of REMICADE® (infliximab)...
20 July 2011 | By Pfizer
Pfizer Inc. and Icagen, Inc. announced that they have entered into a definitive merger agreement....
20 July 2011 | By AstraZeneca
The US FDA has approved BRILINTA (ticagrelor) tablets...
20 July 2011 | By Merck
Merck has signed a new non-exclusive agreement with Roche...
20 July 2011 | By AstraZeneca
FDA Endocrinologic and Metabolic Drugs Advisory Committee meeting outcome...
20 July 2011 | By Idera Pharmaceuticals
Idera Pharmaceuticals announced the receipt of a verbal communication from the U.S. FDA that a proposed Phase 2 protocol...